Journal article · 2023 · Open access

Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β

Ulrich Hommel, Konstanze Hurth, Jean‐Michel Rondeau, Anna Vulpetti, Daniela Ostermeier, Andreas Boettcher, Jacob P. Brady, Michael Hediger, Sylvie Lehmann, Elke Koch, Anke Blechschmidt, Rina Yamamoto and 12 more

Nature Communications, 14(1), 5497 · Published 7 September 2023 · DOI 10.1038/s41467-023-41190-0

Open PDFView at the publisherCite this paper

In brief

“Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β” is a 2023 journal article by Ulrich Hommel and 23 co-authors, published in Nature Communications. OpenAlex counts 49 citations as of 21 November 2026, which puts it in the top 1% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Nature Communications.

Citations
49
Most cited in
2026 (25)
Field-weighted impact
4.33
References
57
Authors
24

Abstract

Human interleukin-1β (hIL-1β) is a pro-inflammatory cytokine involved in many diseases. While hIL-1β directed antibodies have shown clinical benefit, an orally available low-molecular weight antagonist is still elusive, limiting the applications of hIL-1β-directed therapies. Here we describe the discovery of a low-molecular weight hIL-1β antagonist that blocks the interaction with the IL-1R1 receptor. Starting from a low affinity fragment-based screening hit 1, structure-based optimization resulted in a compound (S)-2 that binds and antagonizes hIL-1β with single-digit micromolar activity in biophysical, biochemical, and cellular assays. X-ray analysis reveals an allosteric mode of action that involves a hitherto unknown binding site in hIL-1β encompassing two loops involved in hIL-1R1/hIL-1β interactions. We show that residues of this binding site are part of a conformationally excited state of the mature cytokine. The compound antagonizes hIL-1β function in cells, including primary human fibroblasts, demonstrating the relevance of this discovery for future development of hIL-1β directed therapeutics.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hommel, U., Hurth, K., Rondeau, J., Vulpetti, A., Ostermeier, D., Boettcher, A., Brady, J. P., Hediger, M., Lehmann, S., Koch, E., Blechschmidt, A., Yamamoto, R., Dottorello, V. T., Haenni‐Holzinger, S., Kaiser, C., Lehr, P., Lingel, A., Mureddu, L. G., Schleberger, C., . . . Bornancin, F. (2023). Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β. Nature Communications, 14(1), 5497. https://doi.org/10.1038/s41467-023-41190-0

MLA 9

Hommel, Ulrich, et al. “Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β.” Nature Communications, vol. 14, no. 1, 2023, p. 5497. https://doi.org/10.1038/s41467-023-41190-0.

Chicago

Hommel, Ulrich, Konstanze Hurth, Jean‐Michel Rondeau, Anna Vulpetti, Daniela Ostermeier, Andreas Boettcher, Jacob P. Brady, et al. 2023. “Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β.” Nature Communications 14 (1): 5497. https://doi.org/10.1038/s41467-023-41190-0.

Harvard

Hommel, U. et al. (2023) ‘Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β’, Nature Communications, 14(1), p. 5497. doi:10.1038/s41467-023-41190-0.

IEEE

U. Hommel et al., “Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β,” Nature Communications, vol. 14, no. 1, p. 5497, 2023, doi: 10.1038/s41467-023-41190-0.

BibTeX

@article{hommel2023discovery,
  title     = {{Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β}},
  author    = {Hommel, Ulrich and Hurth, Konstanze and Rondeau, Jean‐Michel and Vulpetti, Anna and Ostermeier, Daniela and Boettcher, Andreas and Brady, Jacob P. and Hediger, Michael and Lehmann, Sylvie and Koch, Elke and Blechschmidt, Anke and Yamamoto, Rina and Dottorello, Valentina Tundo and Haenni‐Holzinger, Sandra and Kaiser, Christian and Lehr, Philipp and Lingel, Andreas and Mureddu, Luca G. and Schleberger, Christian and Blank, Jutta and Ramage, Paul and Freuler, Felix and Eder, Joerg and Bornancin, Frédéric},
  journal   = {Nature Communications},
  year      = {2023},
  volume    = {14},
  number    = {1},
  pages     = {5497},
  doi       = {10.1038/s41467-023-41190-0},
  url       = {https://doi.org/10.1038/s41467-023-41190-0}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20241111
20251313
20262525

Its field-weighted citation impact is 4.33: it has been cited 4.33 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions

  • IL-1β
  • IL-1 receptor 1
  • allosteric site
  • fragment screening
  • structure-guided optimization
  • inflammatory cytokines

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Hommel, U., Hurth, K., Rondeau, J., Vulpetti, A., Ostermeier, D., Boettcher, A., Brady, J. P., Hediger, M., Lehmann, S., Koch, E., Blechschmidt, A., Yamamoto, R., Dottorello, V. T., Haenni‐Holzinger, S., Kaiser, C., Lehr, P., Lingel, A., Mureddu, L. G., Schleberger, C., . . . Bornancin, F. (2023). Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β. Nature Communications, 14(1), 5497. https://doi.org/10.1038/s41467-023-41190-0

How many times has this paper been cited?

49 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Nature Communications: sign in and open the PDF from this page.

Who wrote this paper?

Ulrich Hommel, Konstanze Hurth, Jean‐Michel Rondeau, Anna Vulpetti, Daniela Ostermeier, Andreas Boettcher, Jacob P. Brady, Michael Hediger, Sylvie Lehmann, Elke Koch, Anke Blechschmidt, Rina Yamamoto and 12 more.

What is the DOI of this paper?

10.1038/s41467-023-41190-0, permanently at https://doi.org/10.1038/s41467-023-41190-0. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.